Prosurvival and proapoptotic functions of ERK1/2 activation in murine thymocytes in vitro

Cellular Immunology

Volumn 261, Issue 1, 2010, Pages 29-36

  Smirnova, Irina S ^a   Chang, Steve ^a   Forsthuber, Thomas G ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Apoptosis; ERK; MAPK; Rodent; Thymocyte

Indexed keywords

BIM PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; THYMOCYTE;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BUTADIENES; CELL SURVIVAL; CELLS, CULTURED; ENZYME ACTIVATION; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NITRILES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS; TETRADECANOYLPHORBOL ACETATE; THYMUS GLAND;

MURINAE; RODENTIA;

EID: 73649107871     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2009.10.008     Document Type: Article

References (41)

1. Allan L.A., Morrice N., Brady S., Magee G., Pathak S., and Clarke P.R. Inhibition of caspase-9 through phosphorylation at Thr125 by ERK MAPK. Nat. Cell Biol. 5 (2003) 647-654
2. Le Gall M., Chambard J.C., Breittmayer J.P., Grall D., Pouyssegur J., and Van Obberghen-Schilling E. The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal. Mol. Biol. Cell 11 (2000) 1103-1112
3. Zhuang S., and Schnellmann R.G. A death-promoting role for extracellular signal-regulated kinase. J. Pharmacol. Exp. Ther. 319 (2006) 991-997
4. Alberola-Ila J., and Hernández-Hoyos G. The Ras/MAPK cascade and the control of positive selection. Immunol. Rev. 191 (2003) 79-96
5. Bommhardt U., Scheuring Y., Bickel C., Zamoyska R., and Hünig T. MEK activity regulates negative selection of immature CD4+CD8+ thymocytes. J. Immunol. 164 (2000) 2326-2337
6. Adachi S., and Iwata M. Duration of calcineurin and Erk signals regulates CD4/CD8 lineage commitment of thymocytes. Cell. Immunol. 215 (2002) 45-53
7. Fischer A.M., Katayama C.D., Pages G., Pouyssegur J., and Hedrick S.M. The role of Erk1 and Erk2 in multiple stages of T cell development. Immunity 23 (2005) 431-443
8. 2+ signals activate apoptosis in thymocytes: studies using the Ca(2+)-ATPase inhibitor thapsigargin. Exp. Cell Res. 212 (1994) 84-92
9. Cohen J.J., and Duke R.C. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol. 132 (1984) 38-42
10. Cohen G.M., Sun X.M., Snowden R.T., Ormerod M.G., and Dinsdale D. Identification of a transitional preapoptotic population of thymocytes. J. Immunol. 151 (1993) 566-574
11. Holmström T.H., Schmitz I., Söderström T.S., Poukkula M., Johnson V.L., Chow S.C., Krammer P.H., and Eriksson J.E. MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly. EMBO J. 19 (2000) 5418-5428
12. Herrant M., Luciano F., Loubat A., and Auberger P. The protective effect of phorbol esters on Fas-mediated apoptosis in T cells. Transcriptional and posttranscriptional regulation. Oncogene 21 (2002) 4957-4968
13. Engedal N., and Blomhoff H.K. Combined action of ERK and NF kappa B mediates the protective effect of phorbol ester on Fas-induced apoptosis in Jurkat cells. J. Biol. Chem. 278 (2003) 10934-10941
14. Jamieson C.A.M., and Yamamoto K.R. Crosstalk pathway for inhibition of glucocorticoid-induced apoptosis by T cell receptor signaling. Proc. Natl. Acad. Sci. USA 97 (2000) 7319-7324
15. van den Brink M.R., Kapeller R., Pratt J.C., Chang J.H., and Burakoff S.J. The extracellular signal-regulated kinase pathway is required for activation-induced cell death of T cells. J. Biol. Chem. 274 (1999) 11178-11185
16. Strasser A. The role of BH3-only proteins in the immune system. Nat. Rev. Immunol. 5 (2005) 189-200
17. Bouillet P., Metcalf D., Huang D.C., Tarlinton D.M., Kay T.W., Köntgen F., Adams J.M., and Strasser A. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286 (1999) 1735-1738
18. O'Connor L., Strasser A., O'Reilly L.A., Hausmann G., Adams J.M., Cory S., and Huang D.C. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 17 (1998) 384-395
19. Luciano F., Jacquel A., Colosetti P., Herrant M., Cagnol S., Pages G., and Auberger P. Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function. Oncogene 22 (2003) 6785-6793
20. Putcha G.V., Le S., Frank S., Besirli C.G., Clark K., Chu B., Alix S., Youle R.J., LaMarche A., Maroney A.C., et al. JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis. Neuron 38 (2003) 899-914
21. Clarke A.R., Purdie C.A., Harrison D.J., Morris R.G., Bird C.C., Hooper M.L., and Wyllie A.H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362 (1993) 849-852
22. MacFarlane M., Jones N.A., Dive C., and Cohen G.M. DNA-damaging agents induce both p53-dependent and p53-independent apoptosis in immature thymocytes. Mol. Pharmacol. 50 (1996) 900-911
23. Persons D.L., Yazlovitskaya E.M., and Pelling J.C. Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin. J. Biol. Chem. 275 (2000) 35778-35785
24. Tang D., Wu D., Hirao A., Lahti J.M., Liu L., Mazza B., Kidd V.J., Mak T.W., and Ingram A.J. Erk activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J. Biol. Chem. 277 (2002) 12710-12717
25. Shaul Y.D., and Seger R. The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim. Biophys. Acta 1773 (2007) 1213-1226
26. Kondoh K., and Nishida E. Regulation of MAP kinases by MAP kinase phosphatases. Biochim. Biophys. Acta 1773 (2007) 1227-1237
27. Zhang T., Choy M., Jo M., and Roberson M.S. Structural organization of the rat mitogen-activated protein kinase phosphatase 2 gene. Gene 273 (2001) 71-79
28. Ley R., Balmanno K., Hadfield K., Weston C., and Cook S.J. Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim. J. Biol. Chem. 278 (2003) 18811-18816
29. Smith Ch.A., Williams G.T., Kingstone R., Jenkinson E.J., and Owen J.J.T. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337 (1989) 181-184
30. Takagi Y., Du J., Ma X.Y., Nakashima I., and Nagase F. Phorbol 12-myristate 13-acetate protects Jurkat cells from methylglyoxal-induced apoptosis by preventing c-Jun N-terminal kinase-mediated leakage of cytochrome c in an extracellular signal-regulated kinase-dependent manner. Mol. Pharmacol. 65 (2004) 778-787
31. Tadakuma T., Kizaki H., Odaka C., Kubota R., Ishimura Y., Yagita H., and Okumura K. CD4+CD8+ thymocytes are susceptible to DNA fragmentation induced by phorbol ester, calcium ionophore and anti-CD3 antibody. Eur. J. Immunol. 20 (1990) 779-784
32. Ohoka Y., Kuwata T., Tozawa Y., Zhao Y., Mukai M., Motegi Y., Suzuki R., Yokoyama M., and Iwata M. In vitro differentiation and commitment of CD4+ CD8+ thymocytes to the CD4 lineage, without TCR engagement. Int. Immunol. 8 (1996) 297-306
33. 2+-independent protein kinase C (nPKC) activation and its regulation by calcineurin activation. J. Biol. Chem. 273 (1998) 28392-28398
34. Ley R., Ewings K.E., Hadfield K., Howes E., Balmanno K., and Cook S.J. Extracellular signal-regulated kinases 1/2 are serum-stimulated "Bim(EL) kinases" that bind to the BH3-only protein Bim(EL) causing its phosphorylation and turnover. J. Biol. Chem. 279 (2004) 8837-8847
35. Sinha D., Bannergee S., Schwartz J.H., Lieberthal W., and Levine J.S. Inhibition of ligand-independent ERK1/2 activity in kidney proximal tubular cells deprived of soluble survival factors up-regulates Akt and prevents apoptosis. J. Biol. Chem. 279 (2004) 10962-10972
36. Ebisuy M., Kondoh K., and Nishida E. The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity. J. Cell Sci. 118 (2005) 2997-3002
37. Kim Y.K., Kim H.J., Kwon C.H., Kim J.H., Woo J.S., Jung J.S., and Kim J.M. Role of ERK activation in cisplatin-induced apoptosis in OK renal epithelial cells. J. Appl. Toxicol. 25 (2005) 374-382
38. Al-Ayoubi A., Tarcsafalvi A., Zheng H., Sakati W., and Eblen S.T. ERK activation and nuclear signaling induced by the loss of cell/matrix adhesion stimulates anchorage-independent growth of ovarian cancer cells. J. Cell. Biochem. 105 (2008) 875-884
39. Nyunoya T., Monick M.M., Powers L.S., Yarovinsky T.O., and Hunninghake G.W. Macrophages survive hyperoxia via prolonged ERK activation due to phosphatase down-regulation. J. Biol. Chem. 280 (2005) 26295-26302
40. Morita A., Zhu J., Suzuki N., Enomoto A., Matsumoto Y., Tomita M., Suzuki T., Ohtomo K., and Hosoi Y. Sodium orthovanadate suppresses DNA damage-induced caspase activation and apoptosis by inactivating p53. Cell Death Differ. 13 (2006) 499-511
41. Dent P., Yacoub A., Fisher P.B., Hagan M.P., and Grant S. MAPK pathways in radiation responses. Oncogene 22 (2003) 5885-5896